Tampon samplings with longer cervicovaginal cell exposures are equivalent to two consecutive swabs for the detection of high-risk human papillomavirus

Sexually Transmitted Diseases

Volumn 29, Issue 11, 2002, Pages 628-636

  Harper, Diane M ^a,c   Raymond, Meghan ^a   Noll, Walter W ^a   Belloni, Dorothy R ^a   Duncan, Laura Therrien ^b   Cole, Bernard F ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; SAMPLING; SELF EVALUATION; TAMPON; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0036842225     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200211000-00003     Document Type: Article

References (30)

1. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976; 36:794.
2. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976; 20:505-509.
3. IARC. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Vol. 64: Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer, 1995.
4. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995; 87:796-802.
5. Walboomers J, Jacobs M, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
6. Cates W. Am Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26:52-57.
7. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytogical abnormalities [Review]. JAMA 2002; 287:2120-2129.
8. Schiffman MH, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening results from women in a high-risk province of Costa Rica. JAMA 2000; 283:87-93.
9. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-86.
10. Deleted in proof.
11. Jain S, Tseng CJ, Horng SG, Soong YK, Pao CC. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gyn Oncol 2000; 82:177-180.
12. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Human Pathol 1999; 30:816-825.
13. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynecol 2002; 186:365-373.
14. Moscicki AB. Comparison between methods for human papillomavirus DNA testing: A model for self-testing in young women. J Infect Dis 1993; 167:723-725.
15. Gravitt PE, Lacey JV, Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001;10:95-100.
16. Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect highgrade squamous intraepithelial lesions. CMAJ 2000; 163:513-518.
17. Hillemanns P, Kimmig R, Hüttemann U, Dannecker C, Thaler CJ. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999; 354:1970.
18. Harper DM, Hildesheim A, Cobb JL, Greenberg M, Vaught J, Lorincz AT. Collection devices for human papillomavirus. J Fam Pract 1999; 48:531-535.
19. Fairley CK, Chen S, Tabrizi SN, Quinn MA, McNeil JJ, Garland SM. Tampons: A novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis 1992;165:1103-1106.
20. Coutlee F, Hankins C, Lapointe N. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group. J Med Virol 1997; 51:42-47.
21. Tabrizi SN, Fairley CK, Chen S, et al. Evaluation of patient-administered tampon specimens for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis 2000; 27:133-137.
22. Paterson B, Tabrizi SN, Garland SM, Fairley CK, Bowden FJ. The tampon test for trichomoniasis: A comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Genitourin Med 1998; 74:136-139.
23. Bowden FJ, Paterson BA, Mein J, et al. Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. Sex Transm Infect 1999; 26:431-434.
24. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996; 88:261-268.
25. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection using consensus PCR. In: Herrington CS, McGee JOD, eds. Diagnostic Molecular Pathology: A Practical Approach. Oxford: Oxford University Press, 1992:132-152.
26. StatSoft, Inc. Statistica for Windows [Computer Program Manual]. Tulsa, Oklahoma: StatSoft, 2001.
27. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.
28. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000; 9:945-951.
29. Rep. Thomas A. Coburn (R-OK), HR 3248, 106th Congress, 1st Session, 2001.
30. Castellsague X, Menendex C, Loscertales MP, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001; 358:1429-1430.